ARLENE ORTEGA: Open Payments
NPI 1740708700 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$72,200 in 108 payments from 11 companies in 2025. Trend: 2023 $22,368 · 2024 $39,800 · 2025 $72,200
Speaker / faculty: $53,083Travel & lodging: $13,653Food & beverage: $4,225Consulting: $1,240
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 46 | $32,680 |
| Deciphera Pharmaceuticals Inc. | 15 | $14,058 |
| JAZZ PHARMACEUTICALS INC. | 15 | $11,091 |
| AstraZeneca Pharmaceuticals LP | 16 | $6,962 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $6,793 |
| ABBVIE INC. | 3 | $210 |
| Incyte Corporation | 1 | $124 |
| SpringWorks Therapeutics, Inc. | 1 | $115 |
| Pharmacosmos Therapeutics Inc. | 2 | $108 |
| Genentech USA, Inc. | 1 | $31 |
Products named: Vyloy, QINLOCK, ZIIHERA, FRUZAQLA, IMFINZI, EPKINLY, Jakafi, MONOFERRIC.
Industry payments across CA — which companies pay providers there.
